Desmoglein-1

From WikiMD's WELLNESSPEDIA

(Redirected from Desmoglein 1)

Desmoglein-1 (DSG1) is a protein that in humans is encoded by the DSG1 gene. It is a member of the desmoglein family and cadherin cell adhesion molecule superfamily of proteins.

Function[edit]

Desmoglein-1 is a calcium-binding transmembrane glycoprotein component of desmosomes in vertebrate epithelial cells. Currently, three desmoglein subfamily members have been identified and all are members of the cadherin cell adhesion molecule superfamily. These desmoglein gene family members are located in a cluster on chromosome 18. This protein has been identified as the autoantigen of the autoimmune skin blistering disease pemphigus foliaceus.

Clinical significance[edit]

Mutations in the DSG1 gene are associated with the skin diseases pemphigus, erythroderma, and palmoplantar keratoderma, striate type 1. In pemphigus, the immune system produces antibodies against desmoglein-1, leading to a loss of adhesion between keratinocytes, the predominant cell type in the epidermis. This results in the formation of blisters in the skin and mucous membranes.

Structure[edit]

Desmoglein-1 is a single-pass type I membrane protein. It contains five extracellular cadherin domains, a transmembrane region and a cytoplasmic tail involved in cell signaling. The protein interacts with plakoglobin and plakophilin, which are other constituents of desmosomes.

See also[edit]

References[edit]


External links[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.